Jiajia Xu

Title: Jiajia Xu: Innovator in Pharmaceutical Composition

Introduction

Jiajia Xu is a prominent inventor based in Jiangsu, China. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 2 patents, her work focuses on enhancing the efficacy of treatments for various medical conditions.

Latest Patents

Jiajia Xu's latest patents include a pharmaceutical composition comprising PARP inhibitors. This invention features a solid dispersion for PARP inhibitors, which includes a compound represented by formula I and a carrier material, specifically polyvinylpyrrolidone. The composition is designed for use in the preparation of drugs aimed at treating cancers. Another notable patent is the pregabalin sustained-release preparation. This formulation contains a pharmaceutically active ingredient, pregabalin, along with a gel framework material made from alginic acid and a swellable material containing polyoxyethylene.

Career Highlights

Jiajia Xu is associated with Jiangsu Hengrui Medicine Company Ltd., where she continues to push the boundaries of pharmaceutical innovation. Her work has been instrumental in developing new drug delivery systems that improve patient outcomes.

Collaborations

Throughout her career, Jiajia has collaborated with notable colleagues, including Hao Chen and Xu Wang. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Jiajia Xu's contributions to pharmaceutical science exemplify her dedication to innovation and improving healthcare solutions. Her patents reflect a commitment to advancing drug formulations that can significantly impact cancer treatment and pain management.